Avalo Therapeutics (AVTX) Tax Provisions (2017 - 2026)
Avalo Therapeutics (AVTX) reported Tax Provisions of $18,000 for Q2 2026, up 12.5% from $16,000 a year earlier and up 50.0% from the prior quarter.
Powered by 
Analysis
Avalo Therapeutics (AVTX) Tax Provisions (2017 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Avalo Therapeutics' Tax Provisions came in at $171,000, up 37.9% year-over-year; for FY2025, it came in at $165,000, up 44.7% from FY2024.
- By year, Tax Provisions came in at $114,000 in FY2024 (+714.3%), $14,000 in FY2023 (-50.0%), $28,000 in FY2022 and -$196,000 in FY2021.
- Five-year quarterly Tax Provisions spans a low of -$14,000 in Q3 2024 and a high of $130,000 in Q4 2025.
- Year over year, Tax Provisions has now increased in each of the last three quarters, with growth averaging 43.9% over the last five quarters.
- The high point for year-over-year Tax Provisions in five years was Q3 2021 (growth of 166.7%); the low point was Q3 2022 (a decline of 37.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $12,000 (Q1 2026), $130,000 (Q4 2025) and $11,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.21 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 662.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 654.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -1.01 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -291.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 393.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 242.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -407.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 292.00 Mn |
| 10 | Avalo Therapeutics | 668.42 Mn | 668.42 Mn | - | 18,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18,000.00 |
| Mar 31, 2026 | 12,000.00 |
| Dec 31, 2025 | 130,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Jun 30, 2025 | 16,000.00 |
| Mar 31, 2025 | 8,000.00 |
| Dec 31, 2024 | 114,000.00 |
| Sep 30, 2024 | -14,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Mar 31, 2024 | 7,000.00 |
| Dec 31, 2023 | -9,000.00 |
| Sep 30, 2023 | 8,000.00 |
| Jun 30, 2023 | 7,000.00 |
| Mar 31, 2023 | 8,000.00 |
| Dec 31, 2022 | 8,000.00 |
| Sep 30, 2022 | 5,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Mar 31, 2022 | 9,000.00 |
| Dec 31, 2021 | 4,000.00 |
| Sep 30, 2021 | 8,000.00 |
API Access
Avalo Therapeutics Tax Provisions API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=tax-provisions&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "tax-provisions", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=tax-provisions&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();